Klivira
Request demo

Optimizing Allergy & Immunology Prior Authorizations with Change Healthcare Clearinghouse

Klivira streamlines complex prior authorization workflows for allergy & immunology change healthcare clearinghouse users, automating submissions for high-cost biologics and IVIG.

Revenue cycle leaders and prior authorization coordinators in Allergy & Immunology face significant administrative burden managing prior authorizations for specialized treatments. Manual processes for eligibility checks and PA submissions through various payer channels, including Change Healthcare, often delay patient care. Klivira addresses these challenges by integrating directly with your EMR and leveraging clearinghouse capabilities to automate these critical steps.

Prior Authorization Challenges in Allergy & Immunology

Allergy & Immunology practices frequently manage prior authorizations for high-cost biologics like Xolair, Dupixent, and Nucala, as well as IVIG/SCIG therapies and advanced allergen immunotherapy. These treatments often require extensive clinical documentation and adherence to specific payer medical policies, leading to complex and time-consuming PA workflows.

Common Allergy & Immunology PA Triggers

  • Asthma biologics (e.g., Xolair, Dupixent, Nucala, Tezspire)
  • IVIG / SCIG for primary immunodeficiencies or autoimmune conditions
  • Allergen immunotherapy (initial and maintenance phases)
  • Advanced diagnostic testing (e.g., molecular allergy panels, specific IgE components)
  • Immunomodulators for chronic urticaria or eosinophilic esophagitis

Leveraging Change Healthcare Clearinghouse for A&I Workflows

Change Healthcare, an Optum-owned national clearinghouse, is a central hub for claims, eligibility, and prior authorization transactions. For Allergy & Immunology, integrating Klivira with Change Healthcare means leveraging its robust infrastructure for HIPAA X12 270/271 for eligibility verification and X12 278 for electronic prior authorization submissions.

EMR-to-Payer Integration for Allergy & Immunology PAs

Klivira abstracts relevant clinical data directly from EMRs (e.g., Epic, Cerner) — including diagnostic codes, lab results (e.g., IgE levels, eosinophil counts), and treatment history — to populate prior authorization requests. This data is then formatted for seamless transmission via Change Healthcare's X12 278 gateway to payers, reducing manual data entry and potential errors specific to A&I clinical templates.

Critical Documentation for A&I Prior Authorizations

  • Diagnosis codes (ICD-10) specific to asthma, urticaria, immunodeficiency
  • Clinical notes detailing symptom severity, treatment history, and response
  • Lab results (e.g., IgE, eosinophil count, IgG/IgA/IgM levels)
  • Pulmonary function tests (PFTs) for asthma biologics
  • Evidence of adherence to clinical guidelines (e.g., AAAAI, ACAAI)
  • Patient weight and dosing information for biologics and IVIG

Enhancing Compliance and Turnaround with ePA

By automating the submission of Allergy & Immunology prior authorizations through Change Healthcare's X12 278 transaction, Klivira helps health systems improve adherence to payer requirements and accelerate turnaround times. This electronic pathway, aligned with Da Vinci PAS initiatives and CMS-0057-F, provides a structured and auditable method for managing high-volume A&I PAs.

Frequently asked questions

How does Klivira facilitate prior authorizations for A&I biologics through Change Healthcare?

Klivira integrates with your EMR to automatically extract the clinical data required for biologics like Xolair or Dupixent. This data is then structured into an X12 278 transaction and routed through Change Healthcare to the appropriate payer for electronic submission, eliminating manual portal entries or faxes.

Can we verify patient eligibility for A&I services via Change Healthcare using Klivira?

Yes, Klivira leverages Change Healthcare's X12 270/271 capabilities to automate real-time eligibility and benefits verification directly from your EMR. This ensures that A&I patients have active coverage for specialized treatments like IVIG before services are rendered.

What EMR data points are essential for A&I prior authorizations submitted through Change Healthcare?

Key EMR data points include specific ICD-10 diagnoses, detailed clinical notes on symptom severity and treatment history, relevant lab results (e.g., IgE levels, eosinophil counts, IgG subclasses), pulmonary function test results, and documentation of failed prior therapies. Klivira extracts these to build comprehensive PA requests.

How does this integration improve PA turnaround times for allergy & immunology cases?

By automating data extraction, formatting, and electronic submission via Change Healthcare's X12 278, Klivira significantly reduces the manual effort and delays associated with traditional PA processes. This leads to faster processing by payers, ultimately improving patient access to critical A&I treatments.

Does this solution support prior authorizations for allergen immunotherapy?

Yes, Klivira can manage prior authorizations for allergen immunotherapy, including initial workups and maintenance phases. The system ensures that required documentation, such as allergy testing results and treatment plans, is accurately compiled and submitted through Change Healthcare to meet payer requirements.

Related coverage

Other allergy-immunology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo